Literature DB >> 29485232

GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.

Andrea Kwakowsky1, Beatriz Calvo-Flores Guzmán1, Madhavi Pandya1, Clinton Turner1,2, Henry J Waldvogel1, Richard L Faull1.   

Abstract

Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. GABA type A receptors (GABAA Rs) are severely affected in Alzheimer's disease (AD). However, the distribution and subunit composition of GABAA Rs in the AD brain are not well understood. This is the first comprehensive study to show brain region- and cell layer-specific alterations in the expression of the GABAA R subunits α1-3, α5, β1-3 and γ2 in the human AD hippocampus, entorhinal cortex and superior temporal gyrus. In late-stage AD tissue samples using immunohistochemistry we found significant alteration of all investigated GABAA Rs subunits except for α3 and β1 that were well preserved. The most prominent changes include an increase in GABAA R α1 expression associated with AD in all layers of the CA3 region, in the stratum (str.) granulare and hilus of the dentate gyrus. We found a significant increase in GABAA R α2 expression in the str. oriens of the CA1-3, str. radiatum of the CA2,3 and decrease in the str. pyramidale of the CA1 region in AD cases. In AD there was a significant increase in GABAA R α5 subunit expression in str. pyramidale, str. oriens of the CA1 region and decrease in the superior temporal gyrus. We also found a significant decrease in the GABAA R β3 subunit immunoreactivity in the str. oriens of the CA2, str. granulare and str. moleculare of the dentate gyrus. In conclusion, these findings indicate that the expression of the GABAA R subunits shows brain region- and layer-specific alterations in AD, and these changes could significantly influence and alter GABAA R function in the disease. Cover Image for this issue: doi: 10.1111/jnc.14179.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; GABAA receptor; entorhinal cortex; hippocampus; subiculum; superior temporal gyrus

Mesh:

Substances:

Year:  2018        PMID: 29485232     DOI: 10.1111/jnc.14325

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial.

Authors:  Luciana L Louzada; Flávio V Machado; Juliana L Quintas; Guilherme A Ribeiro; Mônica V Silva; Dayde L Mendonça-Silva; Bruno S B Gonçalves; Otávio T Nóbrega; Einstein F Camargos
Journal:  Neuropsychopharmacology       Date:  2021-10-11       Impact factor: 7.853

Review 2.  Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.

Authors:  Simona Capsoni; Ivan Arisi; Francesca Malerba; Mara D'Onofrio; Antonino Cattaneo; Enrico Cherubini
Journal:  Brain Sci       Date:  2022-06-15

3.  Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer's Disease.

Authors:  Yangjie Jia; Xia Wang; Yanyu Chen; Wenying Qiu; Wei Ge; Chao Ma
Journal:  Mol Neurobiol       Date:  2021-04-27       Impact factor: 5.590

4.  The Neurotransmitter Receptor Architecture of the Mouse Olfactory System.

Authors:  Kimberley Lothmann; Katrin Amunts; Christina Herold
Journal:  Front Neuroanat       Date:  2021-04-23       Impact factor: 3.856

5.  Drinking water temperature affects cognitive function and progression of Alzheimer's disease in a mouse model.

Authors:  Jiang-Ping Wei; Wen Wen; Yuan Dai; Li-Xia Qin; Yue-Qiang Wen; Dayue Darrel Duan; Shi-Jun Xu
Journal:  Acta Pharmacol Sin       Date:  2020-05-25       Impact factor: 6.150

6.  Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer's Disease.

Authors:  Minghui Wang; Aiqun Li; Michiko Sekiya; Noam D Beckmann; Xiuming Quan; Nadine Schrode; Michael B Fernando; Alex Yu; Li Zhu; Jiqing Cao; Liwei Lyu; Emrin Horgusluoglu; Qian Wang; Lei Guo; Yuan-Shuo Wang; Ryan Neff; Won-Min Song; Erming Wang; Qi Shen; Xianxiao Zhou; Chen Ming; Seok-Man Ho; Sezen Vatansever; H Ümit Kaniskan; Jian Jin; Ming-Ming Zhou; Kanae Ando; Lap Ho; Paul A Slesinger; Zhenyu Yue; Jun Zhu; Pavel Katsel; Sam Gandy; Michelle E Ehrlich; Valentina Fossati; Scott Noggle; Dongming Cai; Vahram Haroutunian; Koichi M Iijima; Eric Schadt; Kristen J Brennand; Bin Zhang
Journal:  Neuron       Date:  2020-11-24       Impact factor: 18.688

7.  Reduction in the neuronal surface of post and presynaptic GABAB receptors in the hippocampus in a mouse model of Alzheimer's disease.

Authors:  Alejandro Martín-Belmonte; Carolina Aguado; Rocío Alfaro-Ruíz; Ana Esther Moreno-Martínez; Luis de la Ossa; José Martínez-Hernández; Alain Buisson; Simon Früh; Bernhard Bettler; Ryuichi Shigemoto; Yugo Fukazawa; Rafael Luján
Journal:  Brain Pathol       Date:  2019-12-12       Impact factor: 6.508

8.  An 5 GABAA Receptor Inverse Agonist, 5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures.

Authors:  Chitra Vinnakota; Karan Govindpani; Warren Perry Tate; Katie Peppercorn; Praju Vikas Anekal; Henry John Waldvogel; Richard Lewis Maxwell Faull; Andrea Kwakowsky
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

9.  Prefrontal GABA Levels Correlate with Memory in Older Adults at High Risk for Alzheimer's Disease.

Authors:  Geetanjali Murari; Darren Ri-Sheng Liang; Aliya Ali; Frankie Chan; Mirjam Mulder-Heijstra; Nicolaas Paul L G Verhoeff; Nathan Herrmann; J Jean Chen; Linda Mah
Journal:  Cereb Cortex Commun       Date:  2020-06-08

10.  Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway.

Authors:  Andrea Kwakowsky; Beatriz Calvo-Flores Guzmán; Karan Govindpani; Henry J Waldvogel; Richard L Faull
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.